A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.

Phase 2 Recruiting 90 enrolled Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.

NaSingle-groupOpen-labelDiagnostic

Summary

The main purpose of this study is to evaluate the effectiveness of technetium \[99mTc\]-H7ND injection in the diagnosis of peritoneal metastasis of gastrointestinal malignant tumor. Objective: To evaluate the safety of technetium \[99mTc\]-H7ND injection in the diagnosis of peritoneal metastasis of gastrointestinal malignant tumor. Objective: To explore the diagnostic threshold of technetium \[99mTc\]-H7ND injection for peritoneal metastasis of gastrointestinal malignant tumor.

Timeline

Start: 2025-03-12
Primary completion: 2025-09
Completion: 2025-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Technetium [99mTc]-H7ND	Unknown	—	—

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.

Summary

Timeline

Drugs

Indications